Chemical Industries (Far East) Limited (SGX:C05)
Singapore · Delayed Price · Currency is SGD 0.6100
+0.0150 (2.52%)
Sep 7, 2026, 7:15 PM SGT
SGX:C05 Balance Sheet
Financials in millions SGD. Fiscal year is April - March.
Millions SGD. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 20.09 | 23.47 | 21.44 | 29.44 | 44.98 |
Cash & Short-Term Investments | 20.09 | 23.47 | 21.44 | 29.44 | 44.98 |
Cash Growth | -14.42% | 9.46% | -27.17% | -34.54% | 7.75% |
Accounts Receivable | 11.29 | 11.29 | 11.03 | 15.35 | 16.16 |
Other Receivables | 0.11 | 0.33 | 2.79 | 2.8 | 1 |
Receivables | 11.41 | 11.63 | 13.82 | 18.14 | 17.15 |
Inventory | 3.46 | 5.86 | 7.43 | 8.5 | 9.97 |
Prepaid Expenses | 0.53 | 0.58 | 0.47 | 0.51 | 0.96 |
Other Current Assets | 0.74 | 0.73 | 0.1 | 0.16 | 0.39 |
Total Current Assets | 36.22 | 42.27 | 43.26 | 56.76 | 73.45 |
Property, Plant & Equipment | 19.84 | 20.04 | 27.06 | 20.93 | 20.1 |
Long-Term Investments | 1.36 | 1.22 | 0.95 | 0.95 | 1.01 |
Long-Term Accounts Receivable | - | 1 | 1.95 | 2.85 | - |
Other Long-Term Assets | 73.7 | 73.6 | 74.3 | 64.5 | 58.1 |
Total Assets | 131.11 | 138.13 | 147.52 | 145.99 | 152.65 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 3.24 | 6.5 | 1.96 | 3.16 | 6.94 |
Accrued Expenses | 4.21 | 4.42 | 4.07 | 4.42 | 6.63 |
Short-Term Debt | - | 4.16 | - | - | - |
Current Portion of Leases | 1.23 | 0.93 | 1.03 | 1 | 0.89 |
Current Income Taxes Payable | 0.24 | 0.32 | 0.3 | 0.15 | 1.77 |
Current Unearned Revenue | 0.38 | - | - | 0.91 | 0.21 |
Other Current Liabilities | 6.35 | 6.57 | 0.39 | 0.12 | 0.1 |
Total Current Liabilities | 15.64 | 22.91 | 7.74 | 9.76 | 16.55 |
Long-Term Leases | 1.07 | 0.69 | 1.57 | 2.6 | 3.8 |
Long-Term Deferred Tax Liabilities | 0.07 | 0.08 | 0.94 | 2.17 | 1.91 |
Other Long-Term Liabilities | 8.97 | 8.28 | 8.06 | - | - |
Total Liabilities | 25.75 | 31.95 | 18.31 | 14.52 | 22.26 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 75.95 | 75.95 | 75.95 | 75.95 | 75.95 |
Retained Earnings | 29.24 | 30.54 | 53.14 | 55.5 | 54.46 |
Comprehensive Income & Other | 0.18 | -0.31 | 0.13 | 0.02 | -0.01 |
Shareholders' Equity | 105.36 | 106.18 | 129.21 | 131.47 | 130.39 |
Total Liabilities & Equity | 131.11 | 138.13 | 147.52 | 145.99 | 152.65 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 2.3 | 5.78 | 2.6 | 3.59 | 4.69 |
Net Cash (Debt) | 17.79 | 17.69 | 18.84 | 25.85 | 40.28 |
Net Cash Growth | 0.56% | -6.11% | -27.11% | -35.83% | 11.24% |
Net Cash Per Share | 0.23 | 0.23 | 0.25 | 0.34 | 0.53 |
Filing Date Shares Outstanding | 75.95 | 75.95 | 75.95 | 75.95 | 75.95 |
Total Common Shares Outstanding | 75.95 | 75.95 | 75.95 | 75.95 | 75.95 |
Working Capital | 20.58 | 19.36 | 35.52 | 47 | 56.89 |
Book Value Per Share | 1.39 | 1.40 | 1.70 | 1.73 | 1.72 |
Tangible Book Value | 105.36 | 106.18 | 129.21 | 131.47 | 130.39 |
Tangible Book Value Per Share | 1.39 | 1.40 | 1.70 | 1.73 | 1.72 |
Land | 12.41 | 10.4 | 10.4 | 7.12 | 7.32 |
Buildings | 32.73 | 32.77 | 33.4 | 32.47 | 32.47 |
Machinery | 75.43 | 74.05 | 73.63 | 101.86 | 107.02 |
Construction In Progress | 1.55 | 1.3 | 3.41 | 1.86 | 0.56 |